Evidence map›Paper›PMID 33124553›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020

Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.

Emma M Harding-Esch, Susie E Huntington, Michael J Harvey, Georgie Weston, Claire E Broad, Elisabeth J Adams, S Tariq Sadiq

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Resistance-Guided Therapy for Neisseria gonorrhoeae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  7. Article
  8. The cat is out of the bag - point-of-care testing (POCT) is here to stay.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Emma M Harding-EschApplied Diagnostic Research and Evaluation Unit, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Susie E HuntingtonAquarius Population Health, London, United Kingdom.
Michael J HarveyAquarius Population Health, London, United Kingdom.
Georgie WestonAquarius Population Health, London, United Kingdom.
Claire E BroadApplied Diagnostic Research and Evaluation Unit, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Elisabeth J AdamsAquarius Population Health, London, United Kingdom.
S Tariq SadiqApplied Diagnostic Research and Evaluation Unit, Institute for Infection and Immunity, St George's University of London, London, United Kingdom.
Aquarius Population Health · GBSt George's, University of London · GB

Funding

Department of Health II-LB-0214-20005Medical Research Council G0901608
6 · The paper itself

Abstract

BackgroundWidespread ceftriaxone antimicrobial resistance (AMR) threatens

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGonorrheaPoint-of-Care TestingAmbulatory Care FacilitiesAzithromycinCeftriaxoneCost-Benefit AnalysisEnglandHumansNeisseria gonorrhoeaeSexual HealthAnti-Bacterial AgentsAzithromycinCeftriaxoneantimicrobial resistanceazithromycinceftriaxoneciprofloxacincost-effectivenessNeisseria gonorrhoeaepoint-of-care testSexually transmitted infection

Identifiers

PMID33124553
PMCPMC7596918
OpenAlexW3097234246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.